CUHK Brain Health Longitudinal Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong

About this trial

The goal of this study is to develop a large longitudinal cohort of individuals diagnosed with or at high risk for brain diseases (both neurological and psychiatric in nature), in order to identify risk factors that contribute to neurological and psychiatric diseases over time. The investigators seek to capture relevant information from medical records, electronically administered questionnaires and follow up phone-based interviews. The investigators expect to eventually have sufficient power from our dataset to examine risk factors for a variety of brain disorders, both individually and in aggregate. Our ultimate goal is to offer scientifically validated ways to preserve and promote brain health by working with our patients' needs and tracking their progress over time.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult ≥ 18 years of age

Red group: established diagnosis of one or more neurological and/or psychiatric conditions

Yellow group: high-risk to develop one or more neurological and/or psychiatric conditions

family history (first degree relative) one or more neurological and/or psychiatric conditions

Disqualifiers

None

Trial population

1. Chinese ONLY 2. Hong Kong Resident

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Neuro-QoL questionnaire

    Behavioral

    Follow-up over time will continue (either in-person or over the phone) using the same questionnaires (depending on which group they are belongs to) at approximately 6-month intervals. During each follow-up, participants will be screened for any new signs, symptoms and diagnoses of neurological and/or psychiatric disorders, in order to correlate these outcomes with risk factors captured using the procedures described above.

Treatment groups

5,000 Participants
are divided into 3 treatment groups
Group A: Red group1 intervention
Group B: Yellow group1 intervention
Group C: Green group1 intervention

Trial outcomes

Primary outcomes

1

Risk factors contributing to neurological and psychiatric diseases

The participants' electronic medical records and questionnaires done (either symptomatic or asymptomatic) would be compared with their follow-up electronic medical records/phone follow-up interview and questionnaires done over time.

Time frame
December, 2038

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.